| Literature DB >> 35396396 |
Xinqun Cheng1, Xiang Lei1, Haifeng Wu1, Hong Luo1, Xiaorui Fu1, Yicheng Gao1, Xinhui Wang1, Yanbin Zhu2,3,4, Jincheng Yan5,6,7.
Abstract
The fact that most of the patients with preoperative DVTs after calcaneal fractures are asymptomatic brought challenges to the early intervention, and periodic imaging examinations aggravated the financial burden of the patients in preoperative detumescence period. This study aimed to use routine clinical data, obtained from the database of Surgical Site Infection in Orthopaedic Surgery (SSIOS), to construct and validate a nomogram for predicting preoperative DVT risk in patients with isolated calcaneal fracture. The nomogram was established base on 7 predictors independently related to preoperative DVT. The performance of the model was tested by concordance index (C-index), receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA), and the results were furtherly verified internally and externally. 952 patients were enrolled in this study, of which 711 were used as the training set. The AUC of the nomogram was 0.870 in the training set and 0.905 in the validation set. After internal verification, the modified C-index was 0.846. Calibration curve and decision curve analysis both performed well in the training set and validation set. In short, we constructed a nomogram for predicting preoperative DVT risk in patients with isolated calcaneal fracture and verified its accuracy and clinical practicability.Entities:
Mesh:
Year: 2022 PMID: 35396396 PMCID: PMC8993928 DOI: 10.1038/s41598-022-10002-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Patients selection flowchart.
Univariate analysis of variables with interest between DVT and non-DVT patients.
| Variables | Patients without DVT ( | Patients with DVT ( | |
|---|---|---|---|
| Gender (males) | 625 (91.5%) | 26 (92.9%) | 0.801 |
| Age | 43.0 (33.0, 51.0) | 46.0 (34.3, 58.0) | 0.138 |
| 0.788 | |||
| < 18.5 | 7 (1.0%) | 0 (0.0%) | |
| 18.5–23.9 | 223 (32.7%) | 11 (39.3%) | |
| 24.0–27.9 | 347 (50.8%) | 14 (50.0%) | |
| ≥ 28.0 | 106 (15.5%) | 3 (10.7%) | |
| Hypertension | 48 (7.0%) | 1 (3.6%) | 0.479 |
| Diabetes mellitus | 17 (2.5%) | 0 (0.0%) | 0.398 |
| Heart disease | 6 (0.9%) | 0 (0.0%) | 0.618 |
| Current smoking | 123 (18.0%) | 8 (28.6%) | 0.158 |
| Alcohol consumption | 63 (9.2%) | 5 (17.9%) | 0.128 |
| Living place (rural) | 287 (42.0%) | 11 (39.3%) | 0.774 |
| Previous operation | 25 (3.7%) | 1 (3.6%) | 0.980 |
| History of allergy | 82 (12.0%) | 3 (10.7%) | 0.836 |
| Mechanism (high energy) | 462 (67.6%) | 18 (64.3%) | 0.710 |
| 0.634 | |||
| Type A | 88 (12.9%) | 2 (7.1%) | |
| Type B | 154 (22.5%) | 6 (21.4%) | |
| Type C | 441 (64.6%) | 20 (71.4%) | |
| Time from injury to admission (days) | 1.0 (0.5,3.0) | 4.0 (2.3,6.8) | < 0.001* |
| Time from injury to DUS (days) | 2.0 (1.0,5.0) | 5.0 (3.3,7.0) | < 0.001* |
| RBC (< lower limitation) | 106 (15.5%) | 17 (60.7%) | < 0.001* |
| HCT (< lower limitation) | 210 (30.7%) | 22 (78.6%) | < 0.001* |
| HGB (< lower limitation) | 55 (8.1%) | 11 (39.3%) | < 0.001* |
| PLT (> 300 × 109/L) | 64 (9.4%) | 3 (10.7%) | 0.811 |
| PHR (> 1.62) | 256 (37.5%) | 18 (64.3%) | 0.004* |
| WBC (> 10 × 109/L) | 180 (26.4%) | 8 (28.6%) | 0.794 |
| NEU (> 6.3 × 109/L) | 291 (42.6%) | 14 (50%) | 0.438 |
| LYM (< 1.8 × 109/L) | 453 (66.3%) | 20 (71.4%) | 0.575 |
| NLR (> 3.09) | 430 (63.0%) | 25 (89.3%) | 0.004* |
| TP (< 60 g/L) | 76 (11.1%) | 12 (42.9%) | < 0.001* |
| 42.42 ± 3.95 | 39.64 ± 3.65 | < 0.001* | |
| < 35 g/L | 22 (3.2%) | 2 (7.1%) | 0.260 |
| 5.4 (5.0, 5.9) | 6.0 (5.0, 6.7) | 0.043* | |
| > 6.1 mmol/L | 132 (19.3%) | 11 (39.3%) | 0.010* |
| HCRP (> 23.34 mg/L) | 216 (31.6%) | 15 (53.6%) | 0.015* |
| Sodium (< 135 mmol/L) | 33 (4.8%) | 2 (7.1%) | 0.580 |
| TG (> 1.7 mmol/L) | 119 (17.4%) | 5 (17.9%) | 0.953 |
| TC (> 5.2 mmol/L) | 86 (12.6%) | 1 (3.6%) | 0.153 |
| HDL-C (< 1.1 mmol/L) | 242 (35.4%) | 18 (64.3%) | 0.002* |
| LDL-C (> 3.37 mmol/L) | 106 (15.5%) | 2 (7.1%) | 0.226 |
| VLDL (> 0.78 mmol/L) | 115 (16.8%) | 5 (17.9%) | 0.888 |
| ALT (> 50U/L) | 110 (16.1%) | 7 (25.0%) | 0.213 |
| AST (> 40U/L) | 48 (7.0%) | 3 (10.7%) | 0.459 |
| ALP (> 135U/L) | 6 (0.9%) | 0 (0.0%) | 0.618 |
| D-dimer (> 1.92 mg/L) | 138 (20.2%) | 11 (39.3%) | 0.015* |
| AT III (< 80%) | 33 (4.8%) | 5 (17.9%) | 0.003* |
| PT (> 12.5 s) | 114 (16.7%) | 6 (21.4%) | 0.512 |
| 0.696 | |||
| < 28 | 173 (25.3%) | 9 (32.1%) | |
| > 42 | 2 (0.3%) | 0 (0.0%) | |
| TT (12-17 s) | 0.489 | ||
| < 12 | 21 (3.1%) | 2 (7.1%) | |
| > 17 | 28 (4.1%) | 1 (3.6%) | |
| 0.703 | |||
| < 2 | 13 (1.9%) | 1 (3.6%) | |
| > 4.4 | 101 (14.8%) | 3 (10.7%) |
BMI Body mass index, RBC red blood cell, reference range: Female, 3.5–5.0 × 1012/L; males, 4.0–5.5 × 1012/L; HCT hematocrit, reference range: Females, 35–45%; males, 40–50%; HGB hemoglobin, reference range: Females, 110–150 g/L; males, 120–160 g/L; PLT platelet, PHR the platelet-to-hemoglobin ratio, WBC white blood cell, NEU neutrophil, LYM lymphocyte, NLR the neutrophil-to-lymphocyte ratio, TP total protein, ALB albumin, FBG fasting blood glucose, HCRP high-sensitivity C-reactive protein, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, VLDL very low-density lipoprotein, ALT alanine transaminase, AST aspartate transaminase, ALP alkaline phosphatase, AT III antithrombin III, PT prothrombin time, APTT activated partial thromboplastin time, TT thrombin time, FIB fibrinogen.
*Statistical significance.
Multivariate analyses of the risk factors related to preoperative DVTs following isolated calcaneal fracture.
| Variables | OR and 95%CI | |
|---|---|---|
| FBG (> 6.1 mmol/L) | 3.04 (1.22–7.61) | 0.017 |
| ALB (g/L) | 0.85 (0.76–0.95) | 0.005 |
| D-dimer (> 1.92 mg/L) | 2.76 (1.06–7.20) | 0.038 |
| AT III (< 80%) | 6.89 (1.89–25.11) | 0.003 |
| PHR (> 1.62) | 2.57 (1.01–6.56) | 0.042 |
| NLR (> 3.09) | 6.02 (1.34–27.04) | 0.019 |
| Delay from injury to DUS (days) | 1.42 (1.27–1.60) | < 0.001 |
OR odd ratio, CI confidence interval, FBG fasting blood glucose, ALB albumin, AT III antithrombin III, PHR the platelet-to-hemoglobin ratio, NLR the neutrophil-to-lymphocyte ratio.
Figure 2Nomogram for predicting preoperative DVTs in patients with isolated calcaneal fracture. The sum of the scores of each predictor (D-dimer, albumin, blood glucose, time from injury to DUS, NLR, PHR, and AT III) corresponds to the risk of DVT.
Figure 3Comparison of the receiver operating characteristic curve (ROC) of the nomogram in the training cohort (a) and the validation cohort (b). The area under curve (AUC) were positively correlated with the predictive accuracy of the nomogram.
Figure 4Comparison of the calibration curves of the nomogram in the training cohort (a) and the validation cohort (b). In the calibration curve, the higher the overlap between the predicted curve and the ideal curve, the better the consistency between the predicted probability and the true probability.
Figure 5Comparison of the decision curve analyses (DCA) of the nomogram in the training cohort (a) and the validation cohort (b). The X-axis represents the threshold probability and the Y-axis represents the net benefit. The dotted line represents the nomogram, The black line assumed that no patient has DVT before surgery, while the gray line represented the assumption that all patients have preoperative DVT. The range of threshold probabilities representing positive net benefit is obtained according to the corresponding points of the intersection of the dotted line with the black line and grey line on the X-axis.